Physician profile
Lung K Tan
NPI 1205862778
$6,430.06
in general payments reported to CMS, 2019-2025
33 companies · $794 in 2025
The $794 reported for 2025 was more than what 76% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,894 · 2020: $627 · 2021: $417 · 2022: $543 · 2023: $369 · 2024: $1,786 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,949.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,298.03 | 2019-2025 | Collagenase Santyl, Grafix Pl, Stravix Pl |
| Mimedx Group, INC. | $1,204.35 | 2024-2025 | |
| Stryker Corporation | $674.18 | 2021-2025 | Augment Injectable, Prostep Mica, Ortholoc 3di |
| Koya Medical, INC. | $542.92 | 2024 | Dayspring, Koya Medical |
| Horizon Therapeutics Plc | $498.10 | 2019-2023 | Krystexxa |
| Organogenesis INC. | $338.85 | 2019-2025 | Puraply Wound Matrix |
| Tenex Health INC. | $311.88 | 2020-2021 | |
| Wright Medical Technology, INC. | $205.86 | 2019 | |
| Goode Surgical INC | $191.76 | 2019 | |
| Trice Medical, INC. | $171.48 | 2022 | |
| Zyla Life Sciences, INC. | $143.70 | 2019-2020 | |
| Hydrofera LLC | $123.50 | 2022-2025 | Hydrofera Blue |
| Melinta Therapeutics, LLC | $97.41 | 2019 | |
| Integra Lifesciences Corporation | $89.19 | 2019-2024 | Tcc-Ez |
| Polynovo North America LLC | $78.57 | 2024-2025 | Novosorb Btm |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $71.02 | 2023 | Allograft Tissue, Colink Plating System |
| Surgenex LLC | $62.48 | 2025 | Surmatrix, Pellograft, Ardeograft |
| Paratek Pharmaceuticals, INC. | $54.03 | 2021-2024 | Nuzyra |
| Solventum Corporation | $35.33 | 2024 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Aroa Biosurgery Incorporated | $29.56 | 2019 | |
| Acera Surgical, INC. | $25.63 | 2025 | Restrata Wound Matrix |
| Coloplast Corp | $22.58 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $20.60 | 2025 | |
| Kci USA, INC. | $18.36 | 2019 | |
| Allergan, INC. | $17.21 | 2020 | |
| Convatec INC. | $15.36 | 2025 | |
| Prugen, INC. Pharmaceuticals | $15.26 | 2019 | |
| Medline Industries LP | $14.34 | 2019 | |
| Zimmer Biomet Holdings, INC. | $13.64 | 2019 | |
| Baudax Bio INC. | $13.54 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.16 | 2020 | |
| Assertio Therapeutics, INC. | $11.47 | 2019 | |
| Advanced Oxygen Therapy INC. | $6.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lung Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.